Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Aug 29,2016
Cutting Morrbid RNA Shortens Immune Cell Lifespan
    Gene transcription can be as capricious as the Fates, who personified destiny and reserved the right to cut the thread of life, but it might yet be persuaded to be as balanced as Justice, a sister to the Fates who was dedicated to keeping the order and setting limits to any action. Depending on howRead more
More
Cutting Morrbid RNA Shortens Immune Cell Lifespan
Aug 26,2016
Autism Risk Linked to Banned Chemicals, Not Vaccines
    The search for the underlying causes of autism has sparked heated debates and an unfortunate glut of bad science. Most notable was the thoroughly debunked Wakefield study that erroneously tied vaccinations to the rise in autism rates. Scientists have been trying actively to repair some of the lasting damage that has befallen not only theRead more
More
Autism Risk Linked to Banned Chemicals, Not Vaccines
Aug 26,2016
Put Molecules on the Rack to Extract Structural Secrets
    Enhanced interrogation is coming to molecular structure studies in the form of MOFs, or metal-organic frameworks. These sturdy crystalline networks hold uncooperative molecules still while they are doused with X-rays. Sounds harsh. But resorting to MOFs doesn't stretch, distort, or break molecules. It merely keeps them still for analysis by means of X-ray crystallography orRead more
More
Put Molecules on the Rack to Extract Structural Secrets
Aug 26,2016
Medicilon's Preclinical Pharmacokinetic Study Services
Pharmacokinetics is the study of the way the body deals with the absorption, distribution, metabolism, and excretion of drugs under investigation expressed in mathematical terms. The effects and the duration of action of the drug are also taken into account. With over 12 years of experience of operating a GLP and non-GLP compliant laboratory, MedicilonRead more
More
Medicilon's Preclinical Pharmacokinetic Study Services
Aug 26,2016
FDA grants priority review qualification for ovarian cancer drug candidate Rucaparib
The FDA recently granted Clovis Oncology a priority review. The company is seeking approval for its experimental drug Rucaparib for the treatment of ovarian cancer. Once the news was released, the company’s stock price soared as much as 38%. This PARP inhibitor is being evaluated for advanced ovarian cancer in patients with BRCA mutations (includingRead more
More
Aug 25,2016
Hispanic Paradox Explained through Epigenetics
    A new paper reports that Latinos age at a slower rate than other ethnic groups. The study ("An Epigenetic Clock Analysis of Race/Ethnicity, Sex, and Coronary Heart Disease”), published in Genome Biology, may one day lead to novel approaches that help slow the aging process for everyone, according to lead author Steve Horvath, Ph.D., professor of human genetics atRead more
More
Hispanic Paradox Explained through Epigenetics
Aug 25,2016
Researchers Discover New Inflammatory Disease
    NIH researchers report the discovery of a rare and sometimes lethal inflammatory disease – otulipenia – that primarily affects young children. They have also identified anti-inflammatory treatments that ease some of the patients' symptoms: fever, skin rashes, diarrhea, joint pain, and overall failure to grow or thrive.     Otulipenia is caused by the malfunction of OTULIN,Read more
More
Researchers Discover New Inflammatory Disease
Aug 24,2016
Eye Color Determines Risk for Cancer
    Clinical and epidemiological data have always pointed to eye cancer being more common among those individuals with light eye coloration and fair skin—however, the genetic mechanisms underlying disease development have been largely unknown. Now new research from investigators at The Ohio State University (OSU) and New York University (NYU) sheds light on specific inherited geneticRead more
More
Eye Color Determines Risk for Cancer
Aug 24,2016
Mending of Chromosomal Split Ends Seen in Real Time
A pair of techniques—CRISPR gene editing and single-molecule microscopy—have been put together to subject telomere repair to a new level of scrutiny, one that not only zooms in on single proteins, but also tracks the proteins over time. The proteins, fluorescently labeled versions of telomerase, were observed displaying a kind of probing behavior, rapidly stickingRead more
More
Aug 24,2016
Medicilon's Drug ADME/PK Assays Services
Medicilon's pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, ranging from small molecules to large molecules, such as protein and antibody. The animal species involved in our services are non-human primate, canine, mice, rat, rabbit and etc.Read more
More
Medicilon's Drug ADME/PK Assays Services
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->